This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
BR Brooks , RG Miller , M Swash , TL Munsat , World Federation of Neurology Research Group on Motor Neuron Diseases (2000). El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 1, 293–299.
SW Kim , IS Shin , JM Kim , SY Lim , (2005). Mirtazapine treatment for pathological laughing and crying after stroke. Clinical Neuropharmacology 28, 249–251.
SR Moore , LS Gresham , MB Bromberg , EJ Kasarkis , RA Smith (1997). A self report measure of affective lability. Journal of Neurology, Neurosurgery and Psychiatry 63, 89–93.
Z Nahas , KA Arlinghaus , KJ Kotrla , RR Clearman , MS George (1998). Rapid response of emotional incontinence to selective serotonin reuptake inhibitors. Journal of Neuropsychiatry and Clinical Neurosciences 10, 453–455.
R Ramasubbu (2003). Lamotrigine treatment for post-stroke pathological laughing and crying. Clinical Neuropharmacology 26, 233–235.
H Rosen (2008). Dextromethorphan/quinidine sulfate for pseudobulbar affect. Drugs Today (Barcelona) 44, 661–668.
AG Smith , M Montealegre-Orjuela , JE Douglas , EA Jenkins (2003). Venlafaxine for pathological crying after stroke. Journal of Clinical Psychiatry 64, 731–732.
F Udaka , S Yamao , H Nagata , S Nakamura , M Kameyama (1984). Pathologic laughing and crying treated with levodopa. Archives of Neurology 41, 1095–1096.
HS Wortzel , TJ Oster , CA Anderson , DB Arciniegas (2008). Pathological laughing and crying: epidemiology, pathophysiology and treatment. CNS Drugs 22, 531–545.